Inter-alpha inhibitor protein level in neonates predicts necrotizing enterocolitis

Journal of Pediatrics

Volumn 157, Issue 5, 2010, Pages 757-761

  Chaaban, Hala ^a   Shin, Michael ^b   Sirya, Edward ^b   Lim, Yow Pin ^b   Caplan, Michael ^c   Padbury, James F ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b ProThera Biologics   (United States)

^c EVANSTON HOSPITAL   (United States)

Author keywords

Coefficient of variation; CV; IaIp; Inter alpha inhibitor protein; NEC; Necrotizing enterocolitis; Neonatal intensive care unit; NICU

Indexed keywords

BIOLOGICAL MARKER; HYPERTENSIVE FACTOR; INTER ALPHA INHIBITOR PROTEIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; ALPHA GLOBULIN; INTER-ALPHA-INHIBITOR;

ABDOMINAL DISEASE; ABDOMINAL DISTENSION; ARTICLE; BLOOD TRANSFUSION; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DISEASE COURSE; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; HYPOTENSION; INFLAMMATION; INTENSIVE CARE UNIT; MALE; MEMBRANE RUPTURE; NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN CARE; NEWBORN INTENSIVE CARE; OBSERVATIONAL STUDY; PATHOGENESIS; PERINATAL PERIOD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RADIOGRAPHY; TISSUE INJURY; BLOOD; ENTEROCOLITIS, NECROTIZING; PREDICTIVE VALUE;

ALPHA-GLOBULINS; ENTEROCOLITIS, NECROTIZING; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 77958031671     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2010.04.075     Document Type: Article

References (34)

1. R. Sharma, J. Tepas Jr., M.L. Hudak, D.L. Mollitt, P.S. Wludyka, and R.J. Tseng Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis J Pediatr Surg 42 2007 454 461
2. P.W. Lin, and B.J. Stoll Necrotising enterocolitis Lancet 368 2006 1271 1283
3. W. Hsueh, M.S. Caplan, X.W. Qu, X.D. Tan, I.G. De Plaen, and F. Gonzalez-Crussi Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts Pediatr Dev Pathol 6 2003 6 23
4. C. Young, R. Sharma, M. Handfield, V. Mai, and J. Neu Biomarkers for infants at risk for necrotizing enterocolitis: clues to prevention? Pediatr Res 65 2009 91R 97R
5. Y.P. Lim, K. Bendelja, S.M. Opal, E. Siryaporn, D.C. Hixson, and J.E. Palardy Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis J Infect Dis 188 2003 919 926
6. H.G. Wisniewski, J.C. Hua, D.M. Poppers, D. Naime, and J. Vilcek TNF/IL-1 - inducible protein TSG-6 potentiates plasmin inhibition by inter-alpha inhibitor and exerts a strong anti-inflammatory effect in vivo J Immunol 156 1996 1609 1615
7. E. Fries, and A.M. Blom Bikunin: not just a plasma proteinase inhibitor Int J Biochem Cell Biol 32 2000 125 137
8. Y.W. Baek, S. Brokat, J.F. Padbury, H. Pinar, D.C. Hixson, and Y.P. Lim Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis J Pediatr 143 2003 11 15
9. H. Chaaban, K. Singh, J. Huang, E. Siryaporn, Y.P. Lim, and J.F. Padbury The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis J Pediatr 154 2009 620 622
10. M. Daveau, P. Rouet, M. Scotte, L. Faye, M. Hiron, J.P. Lebreton, and J.P. Salier Human inter-alpha inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins Biochem J 292 Pt 2 1993 485 492
11. R.C. Holman, B.J. Stoll, M.J. Clarke, and R.I. Glass The epidemiology of necrotizing enterocolitis infant mortality in the United States Am J Public Health 87 1997 2026 2031
12. T.A. Markel, P.R. Crisostomo, G.M. Wairiuko, J. Pitcher, B.M. Tsai, and D.R. Meldrum Cytokines in necrotizing enterocolitis Semin Fetal Neonatal Med 13 2006 35 43
13. M. Pourcyrous, S.B. Korones, W. Yang, T.F. Boulden, and H.S. Bada C-reactive protein in the diagnosis, management, and prognosis of neonatal necrotizing enterocolitis Pediatrics 116 2005 1064 1069
14. A.D. Sutherland, R.B. Gearry, and F.A. Frizelle Review of fecal biomarkers in inflammatory bowel disease Dis Colon Rectum 51 2008 1283 1291
15. C.J. Luke, S.C. Pak, Y.S. Askew, T.L. Naviglia, D.J. Askew, and S.M. Nobar An intracellular serpin regulates necrosis by inhibiting the induction and sequelae of lysosomal injury Cell 130 2007 1108 1119
16. E.C. Claud, T. Savidge, and W.A. Walker Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors Pediatr Res 53 2003 419 425
17. I.G. De Plaen, S.X. Liu, R. Tian, I. Neequaye, M.J. May, and X.B. Han Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis Pediatr Res 61 2007 716 721
18. R. D'Inca, E. Dal Pont, V. Di Leo, L. Benazzato, M. Martinato, and F. Lamboglia Can calprotectin predict relapse risk in inflammatory bowel disease? Am J Gastroenterol 103 2008 2007 2014
19. S. Josefsson, S.K. Bunn, and M. Domellöf Fecal calprotectin in very low birth weight infants J Pediatr Gastroenterol Nutr 44 2007 407 413
20. D. Carroll, A. Corfield, R. Spicer, and P. Cairns Faecal calprotectin concentrations and diagnosis of necrotising enterocolitis Lancet 361 2003 310 311
21. Q. Yang, P.B. Smith, R.N. Goldberg, and C.M. Cotten Dynamic change of fecal calprotectin in very low birth weight infants during the first month of life Neonatology 94 2008 267 271
22. F. Guthmann, T. Borchers, C. Wolfrum, T. Wustrack, S. Bartholomaus, and F. Spener Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates Mol Cell Biochem 239 2002 227 234
23. J.P. Derikx, N.J. Evennett, P.L. Degraeuwe, T.L. Mulder, A.A. van Bijnen, and L.W. van Heurn Urine-based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis Gut 56 2007 1473 1475
24. J.J. Enghild, G. Salvesen, I.B. Thogersen, Z. Valnickova, S.V. Pizzo, and S.A. Hefta Presence of the protein-glycosaminoglycan-protein covalent cross-link in the inter-alpha inhibitor - related proteinase inhibitor heavy chain 2/bikunin J Biol Chem 268 1993 8711 8716
25. W. Morelle, C. Capon, M. Balduyck, P. Sautiere, M. Kouach, and C. Michalski Chondroitin sulphate covalently cross-links the three polypeptide chains of inter-alpha trypsin inhibitor Eur J Biochem 221 1994 881 888
26. S. Garantziotis, J.W. Hollingsworth, R.B. Ghanayem, S. Timberlake, L. Zhuo, and K. Kimata Inter-alpha-trypsin inhibitor attenuates complement activation and complement-induced lung injury J Immunol 179 2007 4187 4192
27. J.-P. Salier, P. Rouet, G. Raguenez, and M. Daveau The inter-α-inhibitor family: from structure to regulation Biochem J 351 1996 1 9
28. J. Potempa, K. Kwon, R. Chawla, and J. Travis Inter-alpha trypsin inhibitor. Inhibition spectrum of native and derived forms J Biol Chem 264 1989 15109 15114
29. R. Wu, X. Cui, Y.P. Lim, K. Bendelja, M. Zhou, and H.H. Simms Delayed administration of human inter-alpha inhibitor proteins reduces mortality in sepsis Crit Care Med 32 2004 1747 1752
30. S. Yang, Y.P. Lim, M. Zhou, P. Salvemini, H. Schwinn, and D. Josic Administration of human inter-alpha inhibitors maintains hemodynamic stability and improves survival during sepsis Crit Care Med 30 2002 617 622
31. S.J. Weiss Tissue destruction by neutrophils N Engl J Med 320 1989 652 676
32. J.H. Neijens, J.J. Abbink, Y.T. Wachtfogel, R.W. Colman, A.J. Eerenberg, and D. Dors Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis J Lab Clin Med 119 1992 159 168
33. V. Gordon, K. Klimpel, N. Arora, M.A. Henderson, and S.H. Leppla Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases Infect Immun 63 1995 82 87
34. Singh K, Zhang LX, Bendelja K, Heath R, Murphy S, Sharma, et al. Inter-alpha inhibitor protein (IaIp) administration improves survival from neonatal sepsis in mice. Pediatr Res. In Press.